Target intelligence / Profile preview

Long intergenic non-protein coding RNA 378 (LINC00378)

Target
LINC00378
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

LINC00378 is a member of the long intergenic non-coding RNA (lincRNA) class, a group of transcripts longer than 200 nucleotides that do not overlap any annotated protein-coding genes and are not translated into proteins[1][3][5]. LincRNAs can have diverse and context-dependent biological functions, such as regulating gene expression, modulating chromatin structure, stabilizing RNAs, and participating in enhancer-associated activity[3][5]. The canonical role of lincRNAs is *not* as druggable targets in the same way as receptors, enzymes, or ion channels, but interest in their regulatory involvement in disease processes—primarily cancer—is growing[1][3][5]. There are no established therapies, biomarkers, or safety considerations associated with LINC00378 at present[1]. Information on its precise function is limited relative to better-characterized lincRNAs, such as XIST or HOTAIR, although general lincRNA mechanisms and classifications apply[3][5].

Other names
lincRNAlong intergenic non-coding RNA
02

Biological functions

Transcriptional regulationChromatin remodelingRNA stabilizationPotential enhancer-associated activityFine-tuning tissue-specific gene expression via diverse mechanisms
03

Disease associations

Cancer (some lincRNAs shown to be involved in tumorigenesis; specific roles for LINC00378 remain unclear, but warrant investigation)Other (Potential context-dependent regulatory roles in development, cell fate, and disease, but literature for LINC00378 specifically is limited)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 378 (LINC00378).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 378 (LINC00378).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call